Caw-it, Reycel P.
HRN: 21-53-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2022
MUPIROCIN 2%, 15G (TUBE)
07/12/2022
07/17/2022
TOPICAL
Adequate Amount On Abrasions
Q12
Abrasions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes